Minneapolis, MN, United States of America

Olli Gröhn

This inventor holds 2 USPTO granted patents. Top assignee: Regents of the University of Minnesota. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olli Gröhn. Retrieved from https://idiyas.com/inventor/olli-gröhn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Olli Gröhn: Innovator in Neuromodulation Technology

Introduction

Olli Gröhn is a prominent inventor based in Minneapolis, MN (US). He has made significant contributions to the field of neuromodulation, particularly through his innovative patent that addresses the complexities of neuronal response modulation. His work is vital for advancing medical technologies that can improve patient outcomes.

Latest Patents

Olli Gröhn holds a patent titled "System and method for feedback-driven neuromodulation." This patent describes systems and methods for neuromodulation that involve simultaneous stimulation and reception of neuronal responses. The closed-loop control system he developed allows for the modulation of various parameters of stimulation, including magnitude, frequency, amplitude, time, and phase. This technology is particularly well-suited for deep brain stimulation (DBS) applications, showcasing its potential impact on neurological treatments.

Career Highlights

Olli Gröhn is affiliated with the University of Minnesota, where he continues to engage in groundbreaking research. His work in neuromodulation has positioned him as a key figure in the development of advanced medical devices aimed at treating neurological disorders. His innovative approach to feedback-driven systems has garnered attention in both academic and clinical settings.

Collaborations

Olli Gröhn collaborates with notable colleagues such as Shalom Michaeli and John Thomas Vaughan. These partnerships enhance the research and development efforts in the field of neuromodulation, fostering an environment of innovation and discovery.

Conclusion

Olli Gröhn's contributions to neuromodulation technology exemplify the intersection of innovation and medical science. His patent and ongoing research at the University of Minnesota highlight the importance of developing advanced solutions for neurological challenges. Through his work, he continues to pave the way for future advancements in this critical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…